Improving the recognition and care of patients with long-term health complications of COVID-19
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 448924
Grant search
Key facts
Disease
COVID-19start year
2021Known Financial Commitments (USD)
$397,220.82Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Quinn Kieran L, Chan Timothy, Cheung Angela M, Ghassemi Marzyeh, Herridge Margaret S, Mamdani Muhammad, Razak Fahad, Rosella Laura C, Verma Amol…Research Location
CanadaLead Research Institution
Sinai Health System (Toronto)Research Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Post acute and long term health consequences
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
IMPORTANCE: More than one year into the COVID-19 pandemic, clinicians and researchers are learning that many patients who were infected with COVID-19 develop chronic conditions that negatively affect their overall health. This may occur in older adults with multiple prior chronic conditions, or in younger adults who were relatively healthy prior to infection with COVID-19. Presently, there is limited understanding of how long-term post-COVID-19 conditions and a person's prior chronic conditions impact their overall use of the healthcare system, their chances of dying and the types of care they receive, including at the end of their life. This project aims to study and predict the development of clinical conditions, the types and quality of care patients receive in hospital, their long-term patterns of healthcare needs including end of life care, and their risk of death following their discharge from hospital after COVID-19 infection. METHODS: GEMINI has built a data platform that collects and harmonizes patient data from all medical and intensive care admissions at ~30 hospitals across Ontario (representing ~65% of the province's patients). We will use rich clinical data and leverage advanced methods in machine learning to study healthcare delivery and clinical outcomes up to one-year after initial hospitalization for COVID-19. Our partnerships with key knowledge users helped inform our research questions and will allow immediate application of our findings to directly support Canada's ongoing response to the pandemic. IMPACT: Improving our understanding and recognition of patients with post-COVID-19 conditions will allow us to identify gaps in care. We will focus on defining high-quality care that can enhance recovery, improve clinical outcomes and improve the quality of end-of-life care in patients who die by minimizing inequities in access to this care.